About the Authors
- Theres Fagerberg
-
Contributed equally to this work with: Theres Fagerberg, Vincent Zoete
Affiliations Department of Oncology and Ludwig Center for Cancer Research, University of Lausanne, Lausanne, Switzerland, Swiss Institute of Bioinformatics, Quartier Sorge – Bâtiment Génopode, Lausanne, Switzerland
- Vincent Zoete
-
Contributed equally to this work with: Theres Fagerberg, Vincent Zoete
Affiliation Swiss Institute of Bioinformatics, Quartier Sorge – Bâtiment Génopode, Lausanne, Switzerland
- Sebastien Viatte
-
Current address: Arthritis Research UK Epidemiology Unit, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom
Affiliations Department of Oncology and Ludwig Center for Cancer Research, University of Lausanne, Lausanne, Switzerland, National Center of Competence in Research (NCCR) Molecular Oncology, Epalinges, Switzerland
- Petra Baumgaertner
-
Affiliation Department of Oncology and Ludwig Center for Cancer Research, University of Lausanne, Lausanne, Switzerland
- Pedro M. Alves
-
Current address: Cancer Immunotherapeutics Business Unit, GlaxoSmithKline Vaccines, Rixensart, Belgium
Affiliations Department of Oncology and Ludwig Center for Cancer Research, University of Lausanne, Lausanne, Switzerland, National Center of Competence in Research (NCCR) Molecular Oncology, Epalinges, Switzerland
- Pedro Romero
-
Affiliation Department of Oncology and Ludwig Center for Cancer Research, University of Lausanne, Lausanne, Switzerland
- Daniel E. Speiser
-
Affiliation Department of Oncology and Ludwig Center for Cancer Research, University of Lausanne, Lausanne, Switzerland
- Olivier Michielin
-
* E-mail: Olivier.Michielin@isb-sib.ch
Affiliations Department of Oncology and Ludwig Center for Cancer Research, University of Lausanne, Lausanne, Switzerland, Swiss Institute of Bioinformatics, Quartier Sorge – Bâtiment Génopode, Lausanne, Switzerland, National Center of Competence in Research (NCCR) Molecular Oncology, Epalinges, Switzerland, Multidisciplinary Oncology Center, Lausanne University Hospital (CHUV), Lausanne, Switzerland
Competing Interests
The authors have declared the receipt of funding from a commercial source: Novartis. The authors confirm that this does not alter their adherence to all the PLOS ONE policies on sharing data and materials. The authors do not have any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products.
Author Contributions
Conceived and designed the experiments: PR DES OM. Performed the experiments: TF VZ SV PB PMA. Analyzed the data: TF VZ SV PB PMA. Wrote the paper: TF VZ.